Skip to main content
Journal of Genetic Engineering and Biotechnology
Download PDF

Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer

Journal of Genetic Engineering and Biotechnology volume 19, Article number: 6 (2021) Cite this article

Abstract

Background

Breast cancer is a disease in which cell grows rapidly forming a mass in the breast. HER2 polymorphisms Ile655Val have been studied as biomarkers for breast cancer and may comprise a risk factor of cardiac toxicity for breast cancer-consuming trastuzumab. Aim of work: In this study, we developed a simple, low cost, and rapid test to detect polymorphism at HER2 gene using SYBR Green I-based melting curve method.

Subjects and methods

In this report, we performed allelic discrimination with real-time temperature melting (Tm) Shift SYBR Green I-based melting curve method. The melting profiles of amplified DNA HER-2 Ile655Val and its characteristics were analyzed.

Result

Tm value of HER2 GG and AA alleles were 85 ± 0.14 °C and 82.5 ± 0.23 °C, respectively, while cycle threshold (Ct) value of GG, AG, and AA alleles were 19.6 ± 0.27, 22.5 ± 0.23, 18.6 ± 0.22 correspondingly; furthermore, no template control has shown consisting Ct value at 31.18 ± 0.27. The developed methods’ characteristics were optimum annealing at 62 °C and Kappa coefficient value 1 with the mean almost consistent with PCR-sequencing. The coefficient of variability for intra-assay of GG, AG, and AA was in the range of 0.2–1%, while the coefficient of variability for inter-assay for each were in the range 0.7–1%. Further, based on PCR, shelf-life assay has shown stability for 3 months of storage observation.

Conclusion

This approach may be considered as simple, rapid, and low cost supporting the rapid study of HER2 epidemiology. Furthermore, the developed methods potentially facilitate clinicians in dealing with breast cancer patients, especially in considering about the cardiotoxicity effect of trastuzumab.

Background

According to the World Health Organization, breast cancer, commonly occurs in women with over 2 million new cases diagnosed in 2018 alone globally [1]. Approximately 30% of the total breast cancer sufferers are of type HER-2, which is an invasive and aggressive type of breast cancer. Human epidermal growth factor receptor2 (HER-2) is a proto-oncogene comprising of chromosomal 17q21 and encodes a transmembrane glycoprotein with tyrosine kinase activity. The polymorphism found in codon 655 (ATC/isoleucine to GTC/valine) in the transmembrane domain of the HER-2 protein is related to high risk of breast cancer [2, 3]. The previous study on the meta-analysis of HER-2 Ile655Val polymorphism stated that it significantly contributes to the risk of breast cancer risk [4, 5]. The existence of valine in the transmembrane domain tends to affect the stability of the receptor active state, thereby decreasing the speed of endocytosis and accelerating the receptor recycling, which leads to the formation of breast cancer. However, this is contrary with isoleucine which destabilizes the formation of HER-2 heterodimers [6]. Furthermore, HER2-expressing cells acquired the characteristics of tumor cells [7]. A recent study on 4167 Shanghai patients showed high levels of HER-2 Ile655Val polymorphism present in breast cancer phenotypes in the entire population. Treatment with trastuzumab a monoclonal antibody that specifically binds to HER2 disrupts the downstream pathways of HER-2 Ile655Val polymorphism [8]. Similarly, the presence of Val allele associated with cardiomyocytes was also reported to be highly sensitive to trastuzumab [7, 9, 10]. The distribution of HER-2 polymorphism showed variations in frequency of Val/Val and Ile/Val genotype in different ethnicities such as Caucasian (5.4%, 29.2%), African–Americans (5.4%, 38.9%), Saudi Arabians (2.0%, 17.8%), Chinese (0.3%, 21.7%), and Filipinos (15%, 1.3%). Meanwhile, in African populations, the Val/Val genotype was the same except in Kenya and Sudan with Ile/Val percentages of 26% and 17.3%, respectively [11]. Understanding disease-related single-nucleotide polymorphisms (SNPs) will facilitate HER-2 Ile655Val polymorphism genotyping study.

Most of the studies on HER-2 Ile655Val polymorphism detection were carried out using the PCR-restriction fragment length polymorphism (RFLP) and TaqMan genotyping method [2, 7, 12, 13]. Each has advantages and disadvantages; for instance, the PCR-RFLP is not of high-throughput detection with post-PCR confirmation, while TaqMan is used to detect high throughput in real-time [13,14,15,16,17,18,19]. Here, we performed allelic discrimination with temperature melting (Tm) Shift SYBR Green I methods using two forward primers specific to the targeted allele and one typical reverse primer. The melting temperature was investigated in order to discriminate the alleles.

Subjects and methods

This study was carried out at Molecular Biology and Diagnostic Laboratory LIPI, Cibinong Science Centre, Indonesia.

Subject

Tumor tissue samples were taken from 30 patients (minimal samples) with primary breast cancer by biopsy from several hospitals in the province of West Sumatra, Indonesia. This research had acquired an ethical approval from the Indonesian Ministry of Health and informed consent from patients. The obtained samples were stored at − 20 °C with genomic DNA extracted from the frozen breast cancer tissues using Purelink from Invitrogen. Furthermore, the DNA concentrations were determined by measuring the absorbance rate using a spectrophotometer at 260/280 nm. All of the 30 samples were already checked for its sequence.

Methods

Quantitative real-time PCR

Single-nucleotide polymorphisms (SNPs) play an important role in determining various cancer types and are capable of serving as diagnostic for its treatment. This research utilized two forward primers for each SNP with the first comprising three mismatched bases from 3′ with long GC tails added at 5′ end. Meanwhile, the second is a forward primer that has no mismatch with a short GC tail located at the same position as previous forward primers. A standard reverse primer was designed for both alleles: Forward1: (G allele) 5′GCGGGCAGGGCGGCCCAGCCCTCTGACGTCCAGCG 3′. Forward 2: (A allele) 5′GCGGGCCCAGCCCTCTGACGTCCATCA 3′. Reverse: 5′CACCCCCAAGACCACGACCA3′ as illustrated in ref [14, 19]. The study optimized qPCR primer proportion formulation and an annealing temperature of 60–62 °C. Furthermore, qPCR was conducted in 10 μl volumes with the amplification mixture for each reaction comprising of 3.4 μl PCR Grade Water Thermoscientific, 5 μL 2x KAPA SYBRTM Fast Green I, 0.175 Forward Primer HER-2 gene 1, 0.2 μl Forward primer HER-2 gene 2, 0.3 μl Reverse primer HER-2 gene, and 1 μl DNA template. The temperature cycling process was carried out at 95 °C for 3 s, with 35 cycles of denaturation process at 95 °C for 10 s, annealing at 62 °C for 30 s, extension at 72 °C for 30 s, and a final extension at 72 °C for 30s. Furthermore, the melt curve and peak analyses were carried out immediately at a melting rate value of 0.2 °C/min, from 65 to 95 °C. A graph of − dF/dT against T formula (F is fluorescence, T is temperature) was plotted to determine the melting peaks.

PCR reagent shelf-life assay

Components of PCR regen prepared in shelf assay include Forward GG Primer, Forward AA Primer, Reverse Primer, 2x KAPA SYBRTM Fast Green I, and PCR Grade Water Thermoscientific Nuclease Free. The PCR regen was stored at − 20 °C, 4 °C, and room temperature. Subsequently, the melt peak assay was used to examine the stability value for each reaction daily, weekly, and monthly for 3 months.

Data analysis

The developed methods were examined based on the melt curve and peak analyses. In addition, the repeatability and reproducibility processes were analyzed using inter- and intra-run variability assays supported with Microsoft excel 2003. Meanwhile, the PCR set analysis was performed using SPSS Cohen’s Kappa.

Result

Optimization of SYBR Green I for HER-2 SNP detection

A total of two forward primers were used for the optimization of SYBR Green I-based melting curve method, which is specific to the targeted allele and one standard reverse primer. Furthermore, the primer design was carried out by introducing SNP at the 3′ end and a mismatch at the third bases of the forward primer, with the addition of varying lengths of GC tail.

This research previously optimized the primary proportion to differentiate SNPs and non-SNPs. There were variation A (0.175 μM Fw GG, 0.2 μM Fw AA, and 0.3 μM rev), variation B (0.2 μM Fw GG, 0.2 μM Fw AA, and 0.3 μM rev), variation C (0.3 μM Fw GG, 0.2 μM Fw AA, and 0.2 μM rev), variation D (0.35 μM Fw GG, 0.2 μM Fw AA, and 0.2 μM rev), variation E (0.4 μM Fw GG, 0.2 μM Fw AA, and 0.2 μM rev), and variation F (0.5 μM Fw GG, 0.2 μM Fw AA, and 0.2 μM rev). From those six, variation A has shown the best proportion to differentiate SNPs and non-SNPs. With more concentration of Fw GG, the melt curve will be able to strongly recognize G allele; this effected especially to GG and AG alleles which cannot be differentiated. Furthermore, the best formulation was used to optimize the annealing temperature at 62 °C with a sharper melt curve and peak value, as shown in Fig. 1.

Fig. 1
figure 1

Melting curve and melting peak at 62 °C, 61 °C, and 60 °C annealing temperature (AA: blue, AG: green, GG: red)

Full size image

The methods were repeated with optimum primer proportion and optimum annealing temperature to confirm the consistency of the melting curve and melting peak. The results showed that the created mismatch primers were able to discriminate SNP from non-SNP consistently. Tm value for SNP HER-2 GG and WT (AA) were 85 ± 0.14 °C, and 82.5 ± 0.23, while cycle threshold (Ct) value for GG, AG, and AA were 19.6 ± 0.27, 22.5 ± 0.23, and 18.6 ± 0.22, respectively. The no template control (NTC) consists of Ct value at 31.18 ± 0.27 °C with a distance temperature of 11 °C from the target. Non-specific melt peak appears at a temperature of 90 °C melting upon AG, and slightly on GG, with a melting temperature similar to AA, as shown in Fig. 2.

Fig. 2
figure 2

SYBR Green I-based real-time PCR analysis for the detection of SNP and non-SNP HER-2 Ille655Val

Full size image

Repeatability and reproducibility assay

The reproducibility of the assay was resolute by testing triplicate using inter- and intra-assay comparison, conducted for 3 days. Furthermore, the coefficient of variability for the intra-assay and inter-assay of GG, AG, and AA was in the range of 0.2–1% and 0.7–1%, respectively, as shown in Table 1. These data indicated that the assay was repeatable and highly reproductive, with no pipetting error and low variation.

Table 1 Repeatability and reproducibility of HER-2 Ille655Val real-time assay
Full size table

Assay performance on the clinical sample analyzed with Kappa Cohen

Based on the comparison and direct sequencing results of the developed method with Kappa statistics, a kappa value of 1 was obtained, as shown in Table 2.

Table 2 Results of Tm Shift SYBR Green I and PCR-sequencing of 30 samples
Full size table

Shelf-life assay

Shelf-life test was conducted by observing the consistency of HER-2 SNP melting peak values at chemical regen storage temperatures of − 20 °C, 4 °C, and room temperature for 3 months. All chemical reagents were protected from light, and the tests were investigated five times daily, for 4 days in a week and for 3 months. The result showed that the chemical regent storage at − 20 °C and 4 °C had consistent melt curve and melt peak values for 3 months, while at room temperature it had low and loose genotyping ability after storing for 3 weeks. Figure 3 shows only 3 and 4 weeks of observation, because periods at − 20 °C and 4 °C had a similar melt curve pattern.

Fig. 3
figure 3

Shelf-life assay of chemical used for SYBR Green I for HER-2 SNP detection during storage at room temperature (RT), 4 °C and − 20 °C. a Three-week storages. b Four-week storages

Full size image

Discussion

This study developed HER-2 Ile655Val polymorphism genotyping using qPCR with SYBR Green I as the fluorescence dye. The main advantage of SYBR Green I compared with other real-time dyes is that it is easy to use, cost-effective, and rapid. The amplification for specific DNA targets associated with SYBR Green I binding and its analysis does not use an additional step, with agarose electrophoresis, as the endpoint PCR. Liu et al. and Wang et al. studies were referenced in this study for the development of various genotyping methods. According to Liu et al., an additional mismatched site on the second, third, and fourth sites from 3′ reported different effects on SNP discrimination. The primers’ design had an additional mismatched in the third nucleotide position from the 3′-end, with the highest allele specificity [20].

Furthermore, Wang et al. reported that additional GC tails at the 5′ orientation to forward primer which consists of 14 bp and 6 bp, respectively, for each forward primer increased the method’s discrimination ability and improved the throughput [15]. Based on those two considerations, SNP (GG and AG alleles) and non-SNP (AA allele) HER-2 PCR products are distinguished for each assay in single closed tubes, which eliminates the risk of PCR contamination. In the preliminary study titled “Developed HER-2 I655V detection based on SYBR Green I-based melting curve method,” it was shown that an un-sharp melt curve target and a clearly additional curve appear at temperatures of 75 °C. Additional curve at 75 °C indicates the existence of a dimer primer which means low specificity [21,22,23,24]. To develop a real-time PCR research validation, the specificity, repeatability, reproducibility, and stability parameters of the assays were considered [25, 26].

The annealing temperature is one of the critical factors that affected the primer specificity. However, this study utilized an optimum annealing temperature of 62 °C because the melt curve and melt peak analysis showed sharper and firm values at this point. Each allele, AA, AG, and GG, have specific melt peak patterns and are capable of discriminating against each other. Although the unspecified product that appeared in the AG allele was detected at 90 °C, they were ignored due to different melting temperatures with the targets of 85 ± 0.14 °C for G and 82.5 ± 0.23 for A. Non-specific products also slightly appeared on GG allele detection, with differing melt peaks similar to the AA allele melting temperature. Those unspecific peaks were also ignored because the proportion of the melting peak for the GG allele was consistently higher than the non-specific melting peak. This is different from the GG melt peak pattern, where AG was formed at the same level for both A and G alleles.

Several statistic studies have been carried out to test the accuracy and performance of the diagnostic or detection kit. For the methods’ development accuracy, the developed methods were compared with a standard gold method of PCR-sequencing using 30 frozen breast cancer tissue samples as DNA genomic sources. Based on a statistic study with Kappa Cohen’s analysis, the results meet the requirement by producing one kappa value which means that it is in almost perfect agreement.

Furthermore, the coefficient of variability for intra-assay and inter-assay of GG, AG, and AA were in the range of 0.2–1 and 0.7–1%. These values showed that the acceptable max value is less than 10 and 15%, respectively. This value provides no pipetting error, and the developed methods have high reproducibility [27, 28]. It also reflects the excellent performance of developed qPCR methods [25, 26] while the shelf life of used chemical reagent was stable during the 3-month storage at − 20 °C and 4 °C as shown by the consistent melt curve and melt peak results. In addition, since all reactions are performed and detected in one closed single tube, this eliminates the risk of PCR contamination as another advantage of the developed method.

Conclusions

In conclusion, this study developed a simple and low-cost SYBR Green I-based melting curve method for the rapid detection of HER2 polymorphism. The Tm Shift SYBR Green I-based melting curve method was used to determine the allelic discrimination in real-time followed by the analyses of the melting profiles of amplified DNA HER-2 Ile655Val and its characteristics. The real-time PCR was able to discriminate SNP (GG or AG allele) from non-SNP (AA allele). Furthermore, the Tm value for HER-2 GG and AA alleles were 85 ± 0.14 °C and 82.5 ± 0.23 °C, while Ct value for GG, AG, and AA alleles were 19.6 ± 0.27, 22.5 ± 0.23, and 18.6 ± 0.22, respectively. The NTC comprises of Ct value at 31.18 ± 0.27. The developed methods were obtained at an optimum annealing temperature of 62 °C and Kappa coefficient value of 1, with the mean in accordance with PCR-sequencing. Meanwhile, the coefficient of variability for intra- and inter-assays of GG, AG, and AA were in the ranges of 0.2–1% and 0.7–1%, respectively, with a 3-month stable PCR shelf-life assay stored for observation. These data designated that the assay was repeatable and highly reproducible, with no pipetting error and low variation. Furthermore, the PCR regen shelf-live assay showed stability for 3 months of storage observation. Real-time PCR using SYBR green I Tm Shift for HER-2 SNP Ile655Val was proven as a simple, efficient, specific, and reproducible method. Therefore, this approach might be considered effective to detect HER2-I655V polymorphism in patients with breast cancer, as it could also facilitate the rapid study of HER-2 epidemiology.

Availability of data and materials

All data generated or analyzed during this activity are included in this published article.

Abbreviations

Tm:

Temperature melting

HER-2

Human epidermal growth factor receptor 2

Ile655Val

Isoleusin655Valine

qPCR

Quantitative polymerase chain reaction

RFLP

Restriction fragment length polymorphism

SNP

Single-nucleotide polymorphism

Ct

Cycle threshold

NTC

No template control

References

  1. WHO (2020) Who Report on Cancer.

    Google Scholar 

  2. Mutluhan H, Akbas E, Erdogan NE, Soylemez F, Senli MS, Polat A et al (2008) The influence of HER2 genotypes as molecular markers on breast cancer outcome. DNA Cell Biol 27(10):575–579

    Google Scholar 

  3. Ma Y, Yang J, Zhang P, Liu Z, Yang Z, Qin H (2011) Lack of association between HER2 codon 655 polymorphism and breast cancer susceptibility: meta-analysis of 22 studies involving 19,341 subjects. Breast Cancer Res Treat 125(1):237–241

    Google Scholar 

  4. Lu S, Wang Z, Liu H, Hao X (2010) HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies. Breast Cancer Res Treat 124(3):771–778

    Google Scholar 

  5. Chen W, Yang H, Tang W, Feng S, Wei Y (2014) Updated meta-analysis on HER2 polymorphisms and risk of breast cancer: evidence from 32 studies. Asian Pacific J Cancer Prev 15:9643–9647

    Google Scholar 

  6. Fleishman SJ, Schlessinger J, Ben-Tal N (2002) A putative molecular-activation switch in the transmembrane domain of erbB2. Proc Natl Acad Sci 99(25):15937–15940

    Google Scholar 

  7. Beauclair S, Formento P, Fischel JL, Lescaut W, Largillier R, Chamorey E et al (2007) Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity. Ann Oncol 18(8):1335–1341

    Google Scholar 

  8. Han X, Diao L, Xu Y, Xue W, Ouyang T, Li J et al (2014) Association between the HER2 Ile655Val polymorphism and response to trastuzumab in women with operable primary breast cancer. Ann Oncol 5(6):1158–1164

    Google Scholar 

  9. Speyer J (2002) Cardiac dysfunction in the trastuzumab clinical experience. J Clin Oncol 20(5):1156–1157

    Google Scholar 

  10. Riccio G, Esposito G, Leoncini E, Contu R, Condorelli G, Chiariello M et al (2009) Cardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. FASEB J Off Publ Fed Am Soc Exp Biol 23(9):3171–3178

    Google Scholar 

  11. Ameyaw MM, Tayeb M, Thornton N, Folayan G, Tariq M, Mobarek A et al (2002) Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer. J Hum Genet 47(4):172–175

    Google Scholar 

  12. Breyer JP, Sanders ME, Airey DC, Cai Q, Yaspan BL, Schuyler PA et al (2009) Heritable variation of ERBB2 and breast cancer risk. Cancer Epidemiol Biomarkers Prev 18(4):1252–1258

    Google Scholar 

  13. Desriani HWA, Besari AY (2016) Improved PCR-RFLP method for Her-2 Ile655Val breast cancer patients detection. Int J Adv Sci Eng Inf Technol 6(2):205–209

    Google Scholar 

  14. Germer S, Higuchi R, Germer S, Higuchi R (1999) Single-tube genotyping without oligonucleotide probes single-tube genotyping without oligonucleotide probes. Methods 9(1):72–78

    Google Scholar 

  15. Wang J, Chuang K, Ahluwalia M, Patel S, Umblas M, Mirel D et al (2005) High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques 39(6):885–892

    Google Scholar 

  16. Reed GH, Wittwer CT (2004) Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis. Clin Chem 50(10):1748–1754

    Google Scholar 

  17. Baris I, Etlik O, Koksal V, Ocak Z, Baris ST (2013) SYBR green dye-based probe-free SNP genotyping: introduction of T-Plex real-time PCR assay. Anal Biochem 441(2):225–231

    Google Scholar 

  18. Gentilini F, Turba ME (2014) Optimization of the divergent method for genotyping single nucleotide variations using SYBR Green-based single-tube real-time PCR. Mutat Res Fundam Mol Mech Mutagen 766–767:14–18

    Google Scholar 

  19. Dhas DBB, Hiasindh Ashmi A, Vishnu Bhat B, Parija SC, Banupriya N (2015) Modified low cost SNP genotyping technique using cycle threshold (Ct) & melting temperature (Tm) values in allele specific real-time PCR. Indian J Med Res 142:555–562

    Google Scholar 

  20. Liu J, Huang S, Sun M, Liu S, Liu Y, Wang W et al (2012) An improved allele-specific PCR primer design method for SNP marker analysis and its application. Plant Methods 8(1):34

    Google Scholar 

  21. Budiarto BR, Harahap WA, Desriani D (2016) Development of Sybr Green I-based melting curve method for HER2I655V polymorphism detection in breast cancer. Makara J Health Res 20(2):29–34

    Google Scholar 

  22. Rao XQ, Sun J (2015) Development of SYBR Green I based real-time RT-PCR assay for specific detection of watermelon silver mottle Virus. Iran J Biotechnol 13(3):20–24

    Google Scholar 

  23. Liu Z, Wang F, Yuan L, Zhang X, Ying Q, Yu L et al (2016) Development of a SYBR-Green quantitative PCR assay for the detection and genotyping of different hantaviruses. Int J Mol Med 38(3):951–960

    Google Scholar 

  24. Chen H, Parimelalagan M, Lai YL, Lee KS, Koay ESC, Hapuarachchi HC et al (2015) Development and evaluation of a SYBR Green-based real-time multiplex RT-PCR assay for simultaneous detection and serotyping of dengue and Chikungunya viruses. J Mol Diagnostics 17(6):722–728

    Google Scholar 

  25. Bustin SA (2010) Why the need for qPCR publication guidelines?-The case for MIQE. Methods 50(4):217–226

    Google Scholar 

  26. Saunders N, Zambon M, Sharp I, Siddiqui R, Bermingham A, Ellis J et al (2013) Guidance on the development and validation of diagnostic tests that depend on nucleic acid amplification and detection. J Clin Virol 56(3):260–270

    Google Scholar 

  27. Guo D, Hu W, Xu B, Li J, Li D, Li S et al (2019) Allele-specific real-time PCR testing for minor macrolide-resistant mycoplasma Pneumoniae. BMC Infect Dis 19(1):1–9

    Google Scholar 

  28. Wang Y, Yang K, Bai C, Yin D, Li G, Qi K et al (2017) Development of a SYBR Green I real-time PCR for the detection of the orf virus. AMB Express 7(1):1–6

    Google Scholar 

Download references

Acknowledgements

Not applicable

Funding

The financial support to cover all the materials used in this activity were from the research funding Kegiatan Unggulan dan Kompetitif Untuk Molekular Farming dan bahan baku obat LIPI, P.I Dr. Eng. Desriani.

Author information

Authors and Affiliations

  1. Research Center for Biotechnology, Indonesian Institute of Sciences (LIPI), Jl Raya Cibinong KM 46, Bogor, West Java, Indonesia

    Desriani, Shabrina S. Ghaissani, Senja R. Kinanti & Muhammad A. Warisman

  2. Division of Surgical Oncology Medical School of M. Djamil Hospital, Andalas University, Jl Perintis Kemerdekaan No. 94, Padang, West Sumatra, Indonesia

    Azamris

  3. Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Andalas University, West Sumatra, Indonesia

    N. Fitria

Authors
  1. Desriani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Azamris
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shabrina S. Ghaissani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Senja R. Kinanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Muhammad A. Warisman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N. Fitria
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

D is the research principal investigator and contributed in the funding, manuscript writing, and data analysis. A analyzed the data and samples. SSG, SRK, and MAW provided technical support and analyzed the data. NF took part in the manuscript writing and English check. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Desriani.

Ethics declarations

Ethics approval and consent to participate

Indonesian Health of Ministry approved the study protocol and methodologies. Approval letter number: 053/PEP/01/2012.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Desriani, Azamris, Ghaissani, S.S. et al. Design and characterization of a SYBR Green I-based melting curve method for investigation of HER2I655V polymorphism in breast cancer. J Genet Eng Biotechnol 19, 6 (2021). https://doi.org/10.1186/s43141-020-00108-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43141-020-00108-9

Keywords